IMMUNIC INC (IMUX)       1.36  +0.01 (+0.74%)

1.36  +0.01 (+0.74%)

US4525EP1011 - Common Stock - After market: 1.36 0 (0%)

Buy % Consensus

Analysts have set a mean price target of 21.59. This target is 1487.5% above the current price.
IMUX was analyzed by 12 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about IMUX.
In the previous month the buy percentage consensus was at a similar level.
IMUX was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target

Price Low Median Mean High 1.365.0520.9121.5940.95 - 271.32% 1,437.50% 1,487.50% 2,911.03%

Up and Down Grades

Date Firm Action Rating
2022-10-21 SVB Leerink Downgrade Outperform -> Market Perform
2022-08-08 Aegis Capital Maintains Buy
2022-06-03 SVB Leerink Maintains Outperform
2022-05-18 Piper Sandler Maintains Overweight
2021-09-07 HC Wainwright & Co. Maintains Buy
2021-04-15 Aegis Capital Initiate Buy
2021-03-24 JMP Securities Initiate Market Outperform

Analyst Ratings Stock Screener Links

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA